News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,778 Results
Type
Article (42178)
Company Profile (273)
Press Release (691306)
Multimedia
Podcasts (91)
Webinars (24)
Section
Business (207011)
Career Advice (2408)
Deals (35882)
Drug Delivery (128)
Drug Development (81850)
Employer Resources (185)
FDA (16561)
Job Trends (15203)
News (350038)
Policy (32990)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2667)
Accelerated approval (43)
Adcomms (25)
Allergies (163)
Alliances (50328)
ALS (195)
Alzheimer's disease (1753)
Antibody-drug conjugate (ADC) (371)
Approvals (16874)
Artificial intelligence (604)
Autoimmune disease (227)
Automation (50)
Bankruptcy (364)
Best Places to Work (11786)
BIOSECURE Act (20)
Biosimilars (203)
Biotechnology (178)
Bladder cancer (178)
Brain cancer (63)
Breast cancer (694)
Cancer (5345)
Cardiovascular disease (450)
Career advice (2040)
Career pathing (46)
CAR-T (300)
CDC (53)
Celiac Disease (2)
Cell therapy (806)
Cervical cancer (41)
Clinical research (70512)
Collaboration (1921)
Company closure (4)
Compensation (1266)
Complete response letters (72)
COVID-19 (2742)
CRISPR (101)
C-suite (993)
Cystic fibrosis (149)
Data (7059)
Decentralized trials (3)
Denatured (30)
Depression (156)
Dermatology (57)
Diabetes (554)
Diagnostics (6889)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (48)
Drug discovery (294)
Drug pricing (199)
Drug shortages (30)
Duchenne muscular dystrophy (268)
Earnings (91258)
Editorial (61)
Employer branding (24)
Employer resources (164)
Events (119795)
Executive appointments (1046)
FDA (19984)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1628)
Gene editing (215)
Generative AI (54)
Gene therapy (664)
GLP-1 (1034)
Government (4762)
Grass and pollen (6)
Guidances (396)
Healthcare (19235)
HIV (74)
Huntington's disease (52)
IgA nephropathy (92)
Immunology and inflammation (278)
Immuno-oncology (82)
Indications (157)
Infectious disease (3058)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (276)
Interviews (409)
IPO (16724)
IRA (53)
Job creations (3734)
Job search strategy (1696)
JPM (59)
Kidney cancer (18)
Labor market (92)
Layoffs (566)
Leadership (43)
Legal (7985)
Liver cancer (99)
Longevity (28)
Lung cancer (716)
Lymphoma (407)
Machine learning (52)
Management (63)
Manufacturing (926)
MASH (179)
Medical device (13983)
Medtech (14060)
Mergers & acquisitions (20319)
Metabolic disorders (1428)
mRNA (176)
Multiple sclerosis (174)
NASH (17)
Neurodegenerative disease (386)
Neuropsychiatric disorders (99)
Neuroscience (3151)
Neurotech (1)
NextGen: Class of 2026 (6690)
Non-profit (4673)
Now hiring (73)
Obesity (675)
Opinion (298)
Ovarian cancer (186)
Pain (231)
Pancreatic cancer (255)
Parkinson's disease (338)
Partnered (33)
Patents (555)
Patient recruitment (589)
Peanut (61)
People (60214)
Pharmaceutical (64)
Pharmacy benefit managers (33)
Phase 1 (22001)
Phase 2 (31044)
Phase 3 (23112)
Pipeline (7132)
Policy (306)
Postmarket research (2568)
Preclinical (9323)
Press Release (64)
Prostate cancer (278)
Psychedelics (50)
Radiopharmaceuticals (307)
Rare diseases (1004)
Real estate (6069)
Recruiting (75)
Regulatory (25134)
Reports (56)
Research institute (2472)
Resumes & cover letters (386)
Rett syndrome (32)
RNA editing (18)
RSV (85)
Schizophrenia (165)
Series A (269)
Series B (203)
Service/supplier (12)
Sickle cell disease (106)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (47)
Startups (3711)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (85)
The Weekly (59)
Vaccines (1066)
Venture capital (99)
Weight loss (432)
Women's health (109)
Worklife (21)
Date
Today (118)
Last 7 days (666)
Last 30 days (2751)
Last 365 days (30229)
2026 (8041)
2025 (30428)
2024 (35496)
2023 (40347)
2022 (51529)
2021 (56127)
2020 (54578)
2019 (47322)
2018 (35703)
2017 (32544)
2016 (31925)
2015 (37953)
2014 (31606)
2013 (26666)
2012 (28859)
2011 (29597)
2010 (27595)
Location
Africa (788)
Alabama (90)
Alaska (7)
Arizona (334)
Arkansas (13)
Asia (40009)
Australia (6633)
California (12310)
Canada (3525)
China (1239)
Colorado (524)
Connecticut (522)
Delaware (367)
Europe (87079)
Florida (1853)
Georgia (398)
Hawaii (3)
Idaho (63)
Illinois (964)
India (82)
Indiana (561)
Iowa (23)
Japan (492)
Kansas (130)
Kentucky (45)
Louisiana (39)
Maine (73)
Maryland (1491)
Massachusetts (8799)
Michigan (347)
Minnesota (678)
Mississippi (6)
Missouri (143)
Montana (35)
Nebraska (29)
Nevada (137)
New Hampshire (83)
New Jersey (3274)
New Mexico (29)
New York (3246)
North Carolina (1566)
North Dakota (9)
Northern California (6084)
Ohio (367)
Oklahoma (22)
Oregon (41)
Pennsylvania (2489)
Puerto Rico (27)
Rhode Island (50)
South America (1160)
South Carolina (77)
South Dakota (1)
Southern California (4843)
Tennessee (199)
Texas (1934)
United States (43608)
Utah (367)
Vermont (1)
Virginia (295)
Washington D.C. (81)
Washington State (982)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
733,778 Results for "cria opportunities inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
April 2, 2026
·
4 min read
Press Releases
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
March 12, 2026
·
5 min read
Press Releases
Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities
March 19, 2026
·
4 min read
Press Releases
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
March 23, 2026
·
5 min read
Press Releases
MTF Biologics Announces New Funding Opportunities For 2026
January 30, 2026
·
4 min read
Press Releases
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
April 1, 2026
·
8 min read
Press Releases
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
February 9, 2026
·
8 min read
Press Releases
Breast Cancer 2026 Progress Outlook: New Research Discoveries and Opportunities
February 3, 2026
·
6 min read
Press Releases
Nicoya Lifesciences Announces Launch of FastHDX™, a Millisecond HDX-MS Platform Aimed to Open New Therapeutic Opportunities
March 5, 2026
·
4 min read
Press Releases
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
February 18, 2026
·
6 min read
1 of 73,378
Next
